Israel’s Teva Pharmaceutical Industries Ltd. won permission from the European Commission on Friday to buy U.S. rival Ivax Corp. for $7.4 billion to make Teva the world’s top generic drugmaker.
*For more on this story,
-Advertisement-
Teva Wins EU Approval for Ivax
Want more from the best local business newspaper in the country?
Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!
Would you like to subscribe to Orange County Business Journal?
One-Year for Only $99
- Unlimited access to OCBJ.com
- Daily OCBJ Updates delivered via email each weekday morning
- Journal issues in both print and digital format
- The annual Book of Lists: industry of Orange County's leading companies
- Special Features: OC's Wealthiest, OC 500, Best Places to Work, Charity Event Guide, and many more!
-Advertisement-